本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Xtl生物製藥

0.8936
+0.05366.38%
盤後0.89360.00000.00%16:10 EST
成交量:11.95萬
成交額:10.30萬
市值:845.56萬
市盈率:-0.74
高:0.9083
開:0.7949
低:0.7743
收:0.8400
52周最高:2.57
52周最低:0.5301
股本:946.24萬
流通股本:516.75萬
量比:1.35
換手率:2.31%
股息:- -
股息率:- -
每股收益(TTM):-1.1996
每股收益(LYR):-0.1525
淨資產收益率:-577.13%
總資產收益率:-240.56%
市淨率:-179.91
市盈率(LYR):-5.86

資料載入中...

2025/05/01

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/19

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/11/25

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/01/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露報告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]